Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Oral Edaravone – Introducing a Flexible Treatment Option for Amyotrophic Lateral Sclerosis
Gary L. Pattee, Angela Genge, Philippe Couratier, et al.
Expert Review of Neurotherapeutics (2023) Vol. 23, Iss. 10, pp. 859-866
Open Access | Times Cited: 16

Showing 16 citing articles:

Protein aggregation and therapeutic strategies in SOD1- and TDP-43- linked ALS
Maria Tsekrekou, Μαρία Γιαννάκου, Katerina Papanikolopoulou, et al.
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access | Times Cited: 13
Biomarkers for Managing Neurodegenerative Diseases
Lara Cheslow, Adam E. Snook, Scott A. Waldman
(2024)
Open Access | Times Cited: 6
Edaravone Oral Suspension: A Neuroprotective Agent to Treat Amyotrophic Lateral Sclerosis
Priya Singh, Paul Belliveau, Jennifer Towle, et al.
American Journal of Therapeutics (2024) Vol. 31, Iss. 3, pp. e258-e267
Closed Access | Times Cited: 6
Biomarkers for Managing Neurodegenerative Diseases
Lara Cheslow, Adam E. Snook, Scott A. Waldman
Biomolecules (2024) Vol. 14, Iss. 4, pp. 398-398
Open Access | Times Cited: 5
Therapeutic effect of edaravone on osteoarthritis: targeting NRF2 signaling and mitochondrial function
Chao Jiang, Yuhang Gong, Xinyu Wu, et al.
Journal of Orthopaedic Translation (2025) Vol. 52, pp. 220-232
Closed Access
Intracerebral delivery of the ionic liquid form of edaravone via nose-to-brain delivery route for treating cerebral ischemia/reperfusion injury
Tatsuya Fukuta, Kuniko Yoshimura, Rikuto Ihara, et al.
Journal of Controlled Release (2025), pp. 113834-113834
Closed Access
Recent therapeutic advances in the treatment and management of amyotrophic lateral sclerosis: the era of regenerative medicine
Fabiola De Marchi, Ivan Lombardi, Alessandro Bombaci, et al.
Expert Review of Neurotherapeutics (2025)
Closed Access
Promising approaches to the pathogenetic therapy of amyotrophic lateral sclerosis
М А Кутлубаев
S S Korsakov Journal of Neurology and Psychiatry (2024) Vol. 124, Iss. 4, pp. 13-13
Closed Access | Times Cited: 3
Chronological and Biological Aging in Amyotrophic Lateral Sclerosis and the Potential of Senolytic Therapies
Anna R. Dashtmian, Fereshteh B. Darvishi, W. David Arnold
Cells (2024) Vol. 13, Iss. 11, pp. 928-928
Open Access | Times Cited: 3
Evaluation of the applicability of weak shoulder and arm sparing signs in amyotrophic lateral sclerosis by multiple neurologists and neurology residents: A single‐center study
Yui Sanpei, Keita Yasuda, Yoshiko Takahashi, et al.
Muscle & Nerve (2024)
Open Access | Times Cited: 3
Chemical composition and toxicity studies on Lantana camara L. flower essential oil and its in silico binding and pharmacokinetics to superoxide dismutase 1 for amyotrophic lateral sclerosis (ALS) therapy
Abdullah Haikal, Ahmed R. Ali
RSC Advances (2024) Vol. 14, Iss. 33, pp. 24250-24264
Open Access | Times Cited: 1
Tofersen for SOD1 ALS
William Everett, Robert C. Bucelli
Neurodegenerative Disease Management (2024) Vol. 14, Iss. 5, pp. 149-160
Open Access | Times Cited: 1
Understanding depression with amyotrophic lateral sclerosis: a short assessment of facts and perceptions
K. A. Jellinger
Journal of Neural Transmission (2023) Vol. 131, Iss. 2, pp. 107-115
Closed Access | Times Cited: 2
Disease-Modifying Treatment for Amyotrophic Lateral Sclerosis – A Review on Edaravone
Daniel do Nascimento Antônio, Bruna Laila Tansini
Archives of Neurology and Neuro Disorders (2024) Vol. 4, Iss. 1, pp. 01-05
Open Access
Activity of pyridyl-pyrazolone derivatives against Trypanosoma cruzi
Denise da Gama Jaén Batista, Ludmila Ferreira de Almeida Fiuza, Frédérique Klupsch, et al.
Experimental Parasitology (2024) Vol. 262, pp. 108787-108787
Open Access
Efficacy and tolerability of celastrol and edaravone in the multiple-hit rat model of infantile spasms
Oleksii Shandra, Yongjun Wang, Lisa D. Coles, et al.
Epilepsy & Behavior (2024) Vol. 162, pp. 110159-110159
Closed Access
A protocol for directly accessing geminal C-4 diarylated pyrazol-5(4H)-ones via tandem C–H aryne insertion and their inceptive neurobiological evaluation
K. A. Sudarshana, Manas Jyoti Sarma, Mydhili Radhakrishnan, et al.
Organic & Biomolecular Chemistry (2023) Vol. 22, Iss. 4, pp. 714-719
Closed Access
Page 1

Scroll to top